GLU-xx Formulations in Individuals With Impaired Glucose Tolerance
Clinical trial NCT01468376 · TERMINATED
Trial details
- NCT number
- NCT01468376
- Sponsor
- Afexa Life Sciences Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-01-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.